Previous Article | Next Article 
Journal of Clinical Microbiology, December 1999, p. 4099-4106, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Mutation Patterns of the Reverse Transcriptase and
Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients
Undergoing Combination Therapy: Survey of 787 Sequences
Nouara
Yahi,1
Catherine
Tamalet,1
Christian
Tourrès,1
Natacha
Tivoli,1
Franck
Ariasi,2
Françoise
Volot,3
Jean-Albert
Gastaut,4
Hervé
Gallais,4
Jacques
Moreau,4 and
Jacques
Fantini2,*
Laboratoire de Virologie, UF SIDA, CHRU de la
Timone,1 Laboratoire de Biochimie et
Biologie de la Nutrition, CNRS ESA 6033, Faculté des Sciences
St Jérôme,2 Service de
l'Information Médicale, CHRU de la
Timone,3 and
CISIH,4 13005 Marseille, France
Received 9 April 1999/Returned for modification 24 June
1999/Accepted 23 August 1999
The aim of the present study was to evaluate the
resistance-associated mutations in 302 human immunodeficiency virus
type 1 (HIV-1)-infected patients receiving combination therapy and monitored in Marseille, France, hospitals from January 1997 to June
1998. In the reverse transcriptase (RT) gene, the most frequent mutations were found at codons 215 (53%), 41 (34%), and 67, 70, 184, and 210 (>20%). One deletion and two insertions in the
3-
4 hairpin loop of the finger subdomain (codon 69) were detected. Interesting associations and/or exclusions of specific mutations were
observed. In 96% of RT genes, a mutation at codon 70 (most frequently,
K70R) was associated with a wild-type genotype at position 210 (P < 10
5). Similarly, a mutation at
codon 210 (most frequently, L210W) was generally associated with
mutations at codons 41 (92%) and 215 (96%) but not at codon 219 (16%) or codon 70 (4%) (P < 10
5). In
the protease gene, the most prevalent mutations were at codons 63 (84%), followed by codons 10, 36, 71, 77, and 93 (ca. 20%). As for
RT, pairwise associations of mutations were observed. Analysis of the
mutation patterns for patients with undetectable HIV-1 loads revealed a
high proportion (65%) of wild-type RT genotypes but only 18%
wild-type protease genotypes. For patients with high viral loads
(>100,000 copies/ml), more than 50% of the RT and protease genes
displayed three or more mutations. The significant correlation between
the level of viremia in plasma and the number of resistance
mutations in the protease (P = 0.007) and RT
(P = 0.00078) genes strengthens the importance of
defining the genotype of the predominant HIV-1 quasispecies before
initiating antiretroviral therapy.
*
Corresponding author. Mailing address: Laboratoire de
Biochimie et Biologie de la Nutrition, ESA-CNRS 6033, Faculté des
Sciences de St Jérôme, 13397 Marseille Cedex 20, France.
Phone: 33 491-288-761. Fax: 33 491-288-4400. E-mail:
JACQUES.FANTINI{at}LBBN.u-3mrs.fr.
Journal of Clinical Microbiology, December 1999, p. 4099-4106, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Garriga, C., Perez-Elias, M. J., Delgado, R., Ruiz, L., Perez-Alvarez, L., Pumarola, T., Lopez-Lirola, A., Gonzalez-Garcia, J., Menendez-Arias, L., on behalf of the Spanish Group for the Study of An,
(2009). HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations. J Antimicrob Chemother
64: 251-258
[Abstract]
[Full Text]
-
Puertas, M. C., Buzon, M. J., Artese, A., Alcaro, S., Menendez-Arias, L., Perno, C. F., Clotet, B., Ceccherini-Silberstein, F., Martinez-Picado, J.
(2009). Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility. J. Virol.
83: 7434-7439
[Abstract]
[Full Text]
-
Armstrong, K. L., Lee, T.-H., Essex, M.
(2009). Replicative Capacity Differences of Thymidine Analog Resistance Mutations in Subtype B and C Human Immunodeficiency Virus Type 1. J. Virol.
83: 4051-4059
[Abstract]
[Full Text]
-
Li, N., Wang, Y., Pothukuchy, A., Syrett, A., Husain, N., Gopalakrisha, S., Kosaraju, P., Ellington, A. D.
(2008). Aptamers that recognize drug-resistant HIV-1 reverse transcriptase. Nucleic Acids Res
36: 6739-6751
[Abstract]
[Full Text]
-
Nikolenko, G. N., Delviks-Frankenberry, K. A., Palmer, S., Maldarelli, F., Fivash, M. J. Jr., Coffin, J. M., Pathak, V. K.
(2007). Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance. Proc. Natl. Acad. Sci. USA
104: 317-322
[Abstract]
[Full Text]
-
Hu, Z., Giguel, F., Hatano, H., Reid, P., Lu, J., Kuritzkes, D. R.
(2006). Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1. J. Virol.
80: 7020-7027
[Abstract]
[Full Text]
-
Svicher, V., Sing, T., Santoro, M. M., Forbici, F., Rodriguez-Barrios, F., Bertoli, A., Beerenwinkel, N., Bellocchi, M. C., Gago, F., d'Arminio Monforte, A., Antinori, A., Lengauer, T., Ceccherini-Silberstein, F., Perno, C. F.
(2006). Involvement of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in the Regulation of Resistance to Nucleoside Inhibitors. J. Virol.
80: 7186-7198
[Abstract]
[Full Text]
-
Winters, M. A., Merigan, T. C.
(2005). Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms. Antimicrob. Agents Chemother.
49: 2575-2582
[Full Text]
-
Miranda, L. R., Gotte, M., Kuritzkes, D. R.
(2005). The L74V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Counteracts Enhanced Excision of Zidovudine Monophosphate Associated with Thymidine Analog Resistance Mutations. Antimicrob. Agents Chemother.
49: 2648-2656
[Abstract]
[Full Text]
-
Mahfoud, R., Mylvaganam, M., Lingwood, C. A., Fantini, J.
(2002). A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction. J. Lipid Res.
43: 1670-1679
[Abstract]
[Full Text]
-
Shafer, R. W.
(2002). Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance. Clin. Microbiol. Rev.
15: 247-277
[Abstract]
[Full Text]
-
Kantor, R., Fessel, W. J., Zolopa, A. R., Israelski, D., Shulman, N., Montoya, J. G., Harbour, M., Schapiro, J. M., Shafer, R. W.
(2002). Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy. Antimicrob. Agents Chemother.
46: 1086-1092
[Abstract]
[Full Text]
-
Imamichi, T., Murphy, M. A., Imamichi, H., Lane, H. C.
(2001). Amino Acid Deletion at Codon 67 and Thr-to-Gly Change at Codon 69 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Novel Drug Resistance Profiles. J. Virol.
75: 3988-3992
[Abstract]
[Full Text]
-
Imamichi, T., Berg, S. C., Imamichi, H., Lopez, J. C., Metcalf, J. A., Falloon, J., Lane, H. C.
(2000). Relative Replication Fitness of a High-Level 3'-Azido-3'-Deoxythymidine-Resistant Variant of Human Immunodeficiency Virus Type 1 Possessing an Amino Acid Deletion at Codon 67 and a Novel Substitution (Thrright-arrowGly) at Codon 69. J. Virol.
74: 10958-10964
[Abstract]
[Full Text]